We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Precision Makes dPCR a Steadily Growing Sector

By LabMedica International staff writers
Posted on 06 Apr 2015
Print article
Kalorama Information (New York, NY, USA) has estimated that the budding market for digital PCR (dPCR) reached USD 175 million in 2014 and anticipated growth to provide products for research and diagnostics in diseases like cancer and neurological disorders.

Findings from Kalorama’s dPCR market analysis are provided in its report “qPCR and dPCR Markets,” covering instruments, reagents, software, and services. The report breaks out the market for clinical (in vitro diagnostics) and research applications sectors.

dPCR uses molecular counting to deliver an absolute measure of target nucleic acid molecules, rather than the relative measure obtained from qPCR. It works by partitioning the sample, into chambers (cdPCR) or droplets (ddPCR), to retain only a small number of DNA molecules of interest.

“dPCR is growing in popularity in labs because it is precise,” said Bruce Carlson, publisher of Kalorama Information, “It directly counts the number of individual target molecules in a sample and does not use approximation through standard curves.” Targets are counted as 1, non-targets are counted as 0. Because of its precision, dPCR is capable of analyzing complex mixtures and of performing procedures where only small sample amounts are available.

Kalorama’s report said that among developed nations, the US and Europe represent approximately 70% the dPCR market, which is anticipated to grow at a steady pace, whereas the qPCR segment is mature. “Companies will be looking to provide products to increase research and diagnostics in diseases like cancer, Alzheimer’s disease, and Parkinson’s disease,” said Mr. Carlson.

The competitive landscape for qPCR and dPCR markets is diverse, including large life sciences companies, large pharmaceutical company divisions, and many smaller niche players. According to the report, leading players in this arena are currently Life Technologies (Thermo Fisher Scientific), Bio-Rad, Qiagen, Roche and Agilent, Fluidigm and RainDance Technologies.

Related Links:

Kalorama Information
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets), report


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.